Stay updated on Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.

Latest updates to the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe New Screenshot shows the same Version History layout with identical fields as the Old Screenshot; only minor styling differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference10%

- Check45 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.2%

- Check59 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed.SummaryDifference0.6%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.6%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple entries related to study statuses and contacts. However, several location-related terms and details have been removed.SummaryDifference32%

Stay in the know with updates to Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.